Purchase Order 75N91020P00332

<p>The National Cancer Institute awarded a purchase order to Northeastern University on July 15, 2015, for $5,100 to process Tufts Food Frequency Questionnaires. Work is performed in Baltimore, Maryland, with an ultimate completion date of July 6, 2016. The order is priced firm fixed price and carries no set-aside designation.</p>

<p>The National Cancer Institute awarded a purchase order to Nanoview Biosciences, Inc. for laboratory testing with a ceiling value of $19,300.00, effective August 25, 2020. Work is performed in Brighton, Massachusetts. The order carries firm fixed price terms and runs through October 16, 2020. No set-aside applied.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for biologicals valued at $13,401.67 on March 12, 2020, with an ultimate completion date of April 9, 2020. Place of performance is Bethesda, Maryland. The order is firm fixed price with no set-aside designation.</p>

<p>The National Cancer Institute issued a purchase order to National Cancer Center, National Research and Development Agency on May 14, 2026, with a ceiling value of $15,075.00 for firm fixed price commercial items. This order replaces PO 75N91021P00879 to correct the UEI number. Work is performed in Bethesda, Maryland, with an ultimate completion date of May 13, 2027.</p>

<p>The National Cancer Institute awarded a purchase order to Eppendorf North America, Inc. for $12,841.60 on September 22, 2020, with completion on December 22, 2020. The order covers laboratory equipment on a firm fixed-price basis. Place of performance is Bethesda, Maryland.</p>

<p>The National Cancer Institute issued a purchase order to The Broad Institute, Inc. for $13,480.01 on January 24, 2019, for custom lab work on a genomics platform. Work is performed in Cambridge, Massachusetts. The order is firm fixed-price with an ultimate completion date of July 25, 2019. No set-aside was used.</p>

<p>The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $17,640 purchase order to Human Metabolome Technologies America, Inc. for testing services. The firm fixed price contract will be performed in Boston, Massachusetts over a three month period concluding in October 2023. The award provides testing services in support of the National Cancer Institute's research efforts. No subcontractors or set aside designations were identified.</p>

The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $23,520 purchase order to Human Metabolome Technologies America, Inc. for laboratory testing services. The firm fixed price contract has a period of performance from August 22, 2023 through November 21, 2023 for work to be conducted in Boston, Massachusetts. No subcontractors or set aside designations were identified. The award provides laboratory testing support for the National...

<p>The National Cancer Institute awarded a purchase order to Illumina, Inc. valued at $13,253.75 on November 19, 2020, for the FY26 UDO Initiative.</p> <p>Performance takes place in Rockville, Maryland. The order is firm fixed price with no set-aside designation. Ultimate completion is scheduled for November 30, 2020.</p>

The National Cancer Institute awarded a purchase order to Arraystar Inc. for $22,176.00 on June 14, 2021, for lab testing services. Work is performed in Rockville, Maryland. The order is firm fixed price with an ultimate completion date of July 14, 2021. The purchase order was issued to administratively de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) in preparation for the September 30, 2026 closing of the period of availability of...